A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery (NCT04829916) | Clinical Trial Compass
CompletedPhase 1
A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery
Germany13 participantsStarted 2021-03-16
Plain-language summary
The purpose of the clinical study is to assess safety, tolerability and pharmacokinetics of RMC-035 for the prevention and treatment of acute kidney injury (AKI) in patients undergoing cardiac surgery.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Key Inclusion Criteria:
* Female and male subjects with an age ≥18 years
* Subject is scheduled for non-emergent (elective) CABG and/or valve surgery (single or multiple valves) with use of cardiopulmonary bypass (CPB)
* Subject has at least ONE of the following risk factors for AKI at screening:
* History of LVEF \<35% for at least 3 months prior to screening assessed by either echocardiography, cardiac MRI or nuclear scan.
* History of previous open chest cavity cardiac surgery with or without CPB
* Confirmed diagnosis of type 2 diabetes (T2DM) at least 3 months prior to screening AND ongoing treatment with an approved anti-diabetic drug
* Age ≥70 years
* Documented history of heart failure NYHA class II or higher for at least 3 months or longer at screening
* Documented history of previous AKI before date of screening independent of the etiology of AKI
* Documented history of anemia with hemoglobin ≤ 11 g/dL (≤6.8 mmol/L) for at least 3 months prior to screening
* Documented history of albuminuria, defined as UACR \>30 mg/g or \> 30 mg/24 hour in a 24-hour urine collection.
* eGFR is ≤ 60 mL/min/1.73 m2 using the Chronic Kidney Disease - Epidemiology Collaboration (CKD-EPI) equation
Key Exclusion Criteria:
* Estimated glomerular filtration rate (eGFR) is \<30 mL/min/1.73 m2 using the Chronic Kidney Disease - Epidemiology Collaboration (CKD-EPI) equation at screening or at baseline
* Subject has surgery scheduled to be performed without CPB ("off-pump"…